This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2023 Sep;13(9):2425.

doi: 10.1007/s13346-023-01354-3.

Retraction Note: A facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers

Poonam Parashar¹, Chandra Bhushan Tripathi¹, Malti Arya¹, Jovita Kanoujia¹, Mahendra Singh¹, Abhishek Yadav¹, Shubhini A Saraf²

Affiliations

Affiliations

¹ Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University (A Central University), U.P, Vidya Vihar, Raebareli Road, Lucknow, 226025, India.
² Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University (A Central University), U.P, Vidya Vihar, Raebareli Road, Lucknow, 226025, India. shubhini.saraf@gmail.com.

PMID: 37081281
DOI: 10.1007/s13346-023-01354-3

Retraction Note: A facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers

Poonam Parashar et al. Drug Deliv Transl Res. 2023 Sep.

. 2023 Sep;13(9):2425.

doi: 10.1007/s13346-023-01354-3.

Authors

Poonam Parashar¹, Chandra Bhushan Tripathi¹, Malti Arya¹, Jovita Kanoujia¹, Mahendra Singh¹, Abhishek Yadav¹, Shubhini A Saraf²

Affiliations

¹ Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University (A Central University), U.P, Vidya Vihar, Raebareli Road, Lucknow, 226025, India.
² Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University (A Central University), U.P, Vidya Vihar, Raebareli Road, Lucknow, 226025, India. shubhini.saraf@gmail.com.

PMID: 37081281
DOI: 10.1007/s13346-023-01354-3

No abstract available

PubMed Disclaimer

Retraction of

A facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers.
Parashar P, Tripathi CB, Arya M, Kanoujia J, Singh M, Yadav A, Saraf SA. Parashar P, et al. Drug Deliv Transl Res. 2019 Feb;9(1):37-52. doi: 10.1007/s13346-018-0575-8. Drug Deliv Transl Res. 2019. Retraction in: Drug Deliv Transl Res. 2023 Sep;13(9):2425. doi: 10.1007/s13346-023-01354-3. PMID: 30178279 Retracted.

Similar articles

Correction to: a facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers.
Parashar P, Tripathi CB, Arya M, Kanoujia J, Singh M, Yadav A, Saraf SA. Parashar P, et al. Drug Deliv Transl Res. 2020 Oct;10(5):1532-1533. doi: 10.1007/s13346-020-00783-8. Drug Deliv Transl Res. 2020. PMID: 32372344
A facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers.
Parashar P, Tripathi CB, Arya M, Kanoujia J, Singh M, Yadav A, Saraf SA. Parashar P, et al. Drug Deliv Transl Res. 2019 Feb;9(1):37-52. doi: 10.1007/s13346-018-0575-8. Drug Deliv Transl Res. 2019. Retraction in: Drug Deliv Transl Res. 2023 Sep;13(9):2425. doi: 10.1007/s13346-023-01354-3. PMID: 30178279 Retracted.
Hyaluronic Acid Decorated Naringenin Nanoparticles: Appraisal of Chemopreventive and Curative Potential for Lung Cancer.
Parashar P, Rathor M, Dwivedi M, Saraf SA. Parashar P, et al. Pharmaceutics. 2018 Mar 12;10(1):33. doi: 10.3390/pharmaceutics10010033. Pharmaceutics. 2018. PMID: 29534519 Free PMC article.
Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine.
Mattheolabakis G, Milane L, Singh A, Amiji MM. Mattheolabakis G, et al. J Drug Target. 2015;23(7-8):605-18. doi: 10.3109/1061186X.2015.1052072. J Drug Target. 2015. PMID: 26453158 Review.
CD44-Targeted Nanocarrier for Cancer Therapy.
Kesharwani P, Chadar R, Sheikh A, Rizg WY, Safhi AY. Kesharwani P, et al. Front Pharmacol. 2022 Mar 31;12:800481. doi: 10.3389/fphar.2021.800481. eCollection 2021. Front Pharmacol. 2022. PMID: 35431911 Free PMC article. Review.

See all similar articles

References

Reference

1. Parashar P, Tripathi CB, Arya M, et al. Correction to: a facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers. Drug Deliv and Transl Res. 2020;10:1532–3. https://doi.org/10.1007/s13346-020-00783-8 . - DOI

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal